中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2015年
19期
1468-1470
,共3页
赵珊珊%金兆辰%虞志新%陶立生
趙珊珊%金兆辰%虞誌新%陶立生
조산산%금조신%우지신%도립생
心脏骤停%乳酸%代谢%预后%脑缺血缺氧
心髒驟停%乳痠%代謝%預後%腦缺血缺氧
심장취정%유산%대사%예후%뇌결혈결양
Heart arrest%Lactic acid%Metabolism%Prognosis%Brain ischemia anoxia
目的 明确早期乳酸清除率与心脏骤停(CA)后患者神经功能预后的相关性.方法 2009年1月至2014年9月镇江市第一人民医院重症医学科CA后恢复自主循环的患者共计74例,收集患者的一般临床资料,包括性别、年龄、CA原因、CA前心律、CA时间、抢救时间、ApacheⅡ评分、平均动脉压(MAP),是否合并抽搐或中枢性高热,同时分别记录患者入科当时乳酸基础值及入科后6h乳酸值,计算患者6h乳酸清除率,并根据脑功能分级(CPC)将患者分为两组:神经功能预后较优组(CPC1-2级,A组)24例及神经功能预后较差组(CPC3-5级,B组)50例.比较两组患者一般临床资料、乳酸水平及乳酸清除率是否存在统计学差异,同时采用logistic回归分析各个临床指标以筛选出对神经功能预后的独立影响因素.结果 A、B两组相比较,性别、年龄、CA原因、CA前心律、Apache Ⅱ评分、MAP、合并抽搐或中枢性高热例数差异无统计学意义(P>0.05),CA时间、抢救时间组间比较差异有统计学意义(P<0.05);两组患者乳酸基础值差异无统计学意义(P>0.05),6h乳酸水平A组(5.3 mmol/L)低于B组(7.1 mmol/L)(t=-3.513),6h乳酸清除率A组高于B组(48.8%比33.7%,t=2.835,P<0.05);logistic回归分析得出6h乳酸清除率及CA时间为影响其神经功能预后的独立因素.结论 早期乳酸清除率与CA后患者神经功能预后可能相关.
目的 明確早期乳痠清除率與心髒驟停(CA)後患者神經功能預後的相關性.方法 2009年1月至2014年9月鎮江市第一人民醫院重癥醫學科CA後恢複自主循環的患者共計74例,收集患者的一般臨床資料,包括性彆、年齡、CA原因、CA前心律、CA時間、搶救時間、ApacheⅡ評分、平均動脈壓(MAP),是否閤併抽搐或中樞性高熱,同時分彆記錄患者入科噹時乳痠基礎值及入科後6h乳痠值,計算患者6h乳痠清除率,併根據腦功能分級(CPC)將患者分為兩組:神經功能預後較優組(CPC1-2級,A組)24例及神經功能預後較差組(CPC3-5級,B組)50例.比較兩組患者一般臨床資料、乳痠水平及乳痠清除率是否存在統計學差異,同時採用logistic迴歸分析各箇臨床指標以篩選齣對神經功能預後的獨立影響因素.結果 A、B兩組相比較,性彆、年齡、CA原因、CA前心律、Apache Ⅱ評分、MAP、閤併抽搐或中樞性高熱例數差異無統計學意義(P>0.05),CA時間、搶救時間組間比較差異有統計學意義(P<0.05);兩組患者乳痠基礎值差異無統計學意義(P>0.05),6h乳痠水平A組(5.3 mmol/L)低于B組(7.1 mmol/L)(t=-3.513),6h乳痠清除率A組高于B組(48.8%比33.7%,t=2.835,P<0.05);logistic迴歸分析得齣6h乳痠清除率及CA時間為影響其神經功能預後的獨立因素.結論 早期乳痠清除率與CA後患者神經功能預後可能相關.
목적 명학조기유산청제솔여심장취정(CA)후환자신경공능예후적상관성.방법 2009년1월지2014년9월진강시제일인민의원중증의학과CA후회복자주순배적환자공계74례,수집환자적일반림상자료,포괄성별、년령、CA원인、CA전심률、CA시간、창구시간、ApacheⅡ평분、평균동맥압(MAP),시부합병추휵혹중추성고열,동시분별기록환자입과당시유산기출치급입과후6h유산치,계산환자6h유산청제솔,병근거뇌공능분급(CPC)장환자분위량조:신경공능예후교우조(CPC1-2급,A조)24례급신경공능예후교차조(CPC3-5급,B조)50례.비교량조환자일반림상자료、유산수평급유산청제솔시부존재통계학차이,동시채용logistic회귀분석각개림상지표이사선출대신경공능예후적독립영향인소.결과 A、B량조상비교,성별、년령、CA원인、CA전심률、Apache Ⅱ평분、MAP、합병추휵혹중추성고열례수차이무통계학의의(P>0.05),CA시간、창구시간조간비교차이유통계학의의(P<0.05);량조환자유산기출치차이무통계학의의(P>0.05),6h유산수평A조(5.3 mmol/L)저우B조(7.1 mmol/L)(t=-3.513),6h유산청제솔A조고우B조(48.8%비33.7%,t=2.835,P<0.05);logistic회귀분석득출6h유산청제솔급CA시간위영향기신경공능예후적독립인소.결론 조기유산청제솔여CA후환자신경공능예후가능상관.
Objective To explore the correlations between early lactate clearance and the prognosis of neural function of patients with cardiac arrest (CA).Methods The total number of patients with CA and restored spontaneous circulation was 74.Their general clinical data such as gender,age,cause of CA,heart rhythm pre-CA,CA duration,resuscitation time,Apache Ⅱ score,mean arterial pressure (MAP) and presence or absence of convulsion or central hyperthermia were recorded.The levels of lactate at admission and after 6 h's therapy were also collected and used for calculating the 6 h lactate clearance rate for each patient.According to the cerebral performance category,they were divided into two groups of better neural function (CPC1-2,A,n =24) and worse neural function (CPC3-5,B,n =50).General clinical data,lactate level and lactate clearance rate of two groups were compared to determine whether or not there was a significant difference.Logistic regression analysis was also used to select independent prognostic factors of neural function.Results No significant differences existed in gender,age,cause of CA,heart rhythm before CA,Apache Ⅱ score,MAP,number of cases with concurrent convulsion or central hyperthermia (P > 0.05).And CA duration and save resuscitation time had significant inter-group differences (7.92 vs 11.16,17.47 vs 23.80,P <0.05).The lactate level at admission had no significant inter-group difference (10.7 vs 11.2,P > 0.05) while the 6 h's lactate level of group A was significantly less than that of group B (7.05 vs 5.26,P < 0.05).And the 6 h lactate clearance rate in group A was also significant higher than that in group B (48.79% vs 33.67%,P<0.05).Logistic regression analysis revealed that 6 h lactate clearance rate and CA duratio were independent prognostic factors for neurological function in post-cardiac arrest patients.Conclusion Early lactate clearance may be associated with the prognosis of neural function for CA patients.